Treatment of hepatitis C virus in the liver transplant recipient
โ Scribed by Lafaine Grant; Jeffrey S. Crippin
- Book ID
- 107556334
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 242 KB
- Volume
- 6
- Category
- Article
- ISSN
- 1092-8472
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Recurrent hepatitis C after liver transplantation is a universal phenomenon. Graft reinfection occurs rapidly; once it is established, allograft cirrhosis and decompensation rapidly ensue in many patients. Treatment with pegylated interferon plus ribavirin is the standard of care among nontransplant
To determine the safety and efficacy of ganciclovir usually experience progressive liver disease over an treatment of hepatitis B virus (HBV) infection after liver accelerated time course and pose a difficult managetransplantation, nine patients (seven males, two females; ment challenge. The treatm
Although rare in the pediatric population, the natural history of hepatitis C virus (HCV) recurrence in pediatric patients undergoing orthotopic liver transplantation (OLT) for end-stage liver disease secondary to HCV has not been well described. We performed an analysis of all 67 pediatric patients
Hepatitis C recurrence after liver transplantation is a serious problem, leading to increased graft loss and morbidity in some individuals. Treatment with interferon and other agents is controversial and not highly efficacious. The use of an effective antiviral agent to reduce or eliminate viral bur